Screening for carcinoma is an important service to provide to patients

Video

Richard Castillo, OD, DO, discusses the key takeaways from his presentation on carcinoma screenings for eyelids, and emphasizes why such screenings are such a critical component of primary eye care.

Optometry Times'® Kassi Jackson sat down with Richard Castillo, OD, DO, consulting ophthalmologist for Northeastern State University's School of Optometry, professor and assistant dean for surgical training and education, to discuss his presentation, "Screening for Carcinoma of the Eyelids," that he is presenting during the 2022 AOA annual meeting in Chicago.

Richard Castillo, OD, DO:

"Did you know that something on the order of 15,000 skin cancers are diagnosed in the US every day, and 10% of those — or 1500 — are on or around the eyelid?

I didn't know that until a few years ago when I started researching this talk and similar talks.

And all of a sudden, you know, I come to the realization that, not only do we have ... 1500 skin cancers on or around the eyelid diagnosed yearly, but one in five adults will come down with some form of skin cancer throughout the course of their lifetime. That's 20% of the population.

That's almost double the number of diabetics, that we have walking around, and as eye care providers: optometrist, ophthalmologist... we are fanatic about screening for diabetes and ocular manifestations of diabetes and making sure everybody gets their yearly DFE. And yet I hear almost nothing over lid cancers."

Key takeaways:

  • Screening for lid cancer is part of primary eye care.
  • Screening involves all the techniques other physicians would use to screen, for example: palpating the lymph nodes

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD; and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
© 2025 MJH Life Sciences

All rights reserved.